Investing.com - J&J (NYSE:JNJ) reported third quarter earnings and revenue that beat analysts' expectations on Tuesday.
The firm reported earnings per share of $2.12 on revenue of $20.73B. Analysts polled by Investing.com forecast EPS of $2 on revenue of $20.1B. That compared to EPS of $2.05 on revenue of $20.35B in the same period a year earlier. The company had reported EPS of $2.58 on revenue of $20.56B in the previous quarter.
J&J follows other major Healthcare sector earnings this month
On October 8, Helen of Troy Ltd reported second quarter EPS of $2.24 on revenue of $414M, compared to forecasts of EPS of $1.88 on revenue of $391.86M.
Neogen earnings missed analysts' expectations on September 24, with first quarter EPS of $0.28 on revenue of $101.42M. Investing.com analysts expected EPS of $0.3 on revenue of $105.16M
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar